'Nucleoside reverse transcriptase inhibitors' presentation slideshows

Care of Patients with HIV/AIDS

Care of Patients with HIV/AIDS. Transmission of HIV. HIV is an obligate virus It cannot survive very long outside of the human body Transmitted from human to human Blood Semen Cervicovaginal secretions Breast milk. Transmission of HIV.

1.13k views • 80 slides

Presented By: Peer Education Training Sites

Presented By: Peer Education Training Sites. Team 1. Team 2. Jeopardy. HIV/STD 101. Peer Advocacy. More Treatment. Challenge Questions. Treatment 101. Prevention/ Transmission. $100. $100. $100. $100. $100. $100. $200. $200. $200. $200. $200. $200. $300. $300. $300.

757 views • 68 slides

Presented By: Peer Education Training Sites

Presented By: Peer Education Training Sites. Team 1. Team 2. Jeopardy. HIV/STD 101. Peer Advocacy. More Treatment. Challenge Questions. Treatment 101. Prevention/ Transmission. $100. $100. $100. $100. $100. $100. $200. $200. $200. $200. $200. $200. $300. $300. $300.

685 views • 68 slides

HIV Drugs, Updates, & the Hope for Entry Inhibitors Kent Williams

HIV Drugs, Updates, & the Hope for Entry Inhibitors Kent Williams Doctor of Pharmacy Candidate 2011 Wingate University School of Pharmacy Saturday, February 19, 2011. Disclosures. I have no conflicts of interest in regard to this program.

613 views • 52 slides

Antiretroviral Agents: HIV & AIDS

Antiretroviral Agents: HIV & AIDS. Shaw Vonder Hoya. Worldwide Prevalence. Types of HIV. HIV type 1: Most common Originated from chimpanzee SIV High infectivity and virulence HIV type 2: Mostly confined to West Africa Came from sooty mangabeys Lower infectivity and virulence

703 views • 43 slides

HIV Nephropathy

HIV Nephropathy. Tuesday Morning Disease Review December 5, 2006 Edmund Huang, M.D. Objectives. Overview of HIV-associated renal diseases Discuss the nephrotoxicity of antiretroviral therapy agents

601 views • 41 slides

Antivirals

Antivirals. Lect 7,8 Sadia Anjum. Targets for Anti-viral therapy. 1. viral attachment to cell and fusion (fusion inhibitors). 2. protein translation in infected cells (interferon). 3. protein processing (specific protease inhibitors). DNA synthetic enzymes (reverse transcriptase

637 views • 39 slides

Overview of Antiretroviral Therapy: Options and Preferred Regimens

Hyman M. Scott, MD, MPH University of California, San Francisco Division of Infectious Diseases & Center for AIDS Prevention Studies. Overview of Antiretroviral Therapy: Options and Preferred Regimens. Disclosures. I have no financial disclosures or conflicts of interest. Goals.

471 views • 37 slides

County of Los Angeles Department of Public Health Division of HIV and STD Programs

The State of the HIV/AIDS Epidemic. County of Los Angeles Department of Public Health Division of HIV and STD Programs Disly Juarez, MPH Health Educator djuarezmunoz@ph.lacounty.gov. 1. Human. Immunodeficiency. Virus. HIV. HIV AIDS. Immune. Acquired. AIDS. Deficiency.

530 views • 35 slides

WHO Procurement, Quality and Sourcing Project: Access to HIV/AIDS Drugs and Diagnostics of Acceptable Quality

WHO Procurement, Quality and Sourcing Project: Access to HIV/AIDS Drugs and Diagnostics of Acceptable Quality. Experience from the Evaluation of Drug Dossiers with Respect to Bioequivalence Data Hans Kemmler Swissmedic, Switzerland. The Prequalification Project.

494 views • 30 slides

Priyo Budi Purwono, dr Kuliah Mikrobiologi

412 views • 28 slides

ANTIRETROVIRAL THERAPY

ANTIRETROVIRAL THERAPY. Dr. Samuel Mwaniki (BPharm., MSc TID, UoN). Definition of ART. Treatment with antiretroviral medicines, against the retrovirus (HIV), which resides and multiplies within the human body HIV; etiological agent of AIDS

656 views • 22 slides